Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Outstanding (Diluted Average) (2022 - 2025)

Praxis Precision Medicines has reported Shares Outstanding (Diluted Average) over the past 4 years, most recently at $22.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $22.5 million for Q4 2025, up 25.68% from a year ago — trailing twelve months through Dec 2025 was $22.5 million (up 25.68% YoY), and the annual figure for FY2025 was $22.5 million, up 25.68%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $22.5 million at Praxis Precision Medicines, up from $22.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for PRAX hit a ceiling of $45.6 million in Q3 2022 and a floor of $3.1 million in Q4 2022.
  • Median Shares Outstanding (Diluted Average) over the past 4 years was $18.4 million (2024), compared with a mean of $19.9 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): tumbled 92.21% in 2023 and later soared 359.38% in 2024.
  • Praxis Precision Medicines' Shares Outstanding (Diluted Average) stood at $3.1 million in 2022, then soared by 114.58% to $6.6 million in 2023, then soared by 171.55% to $17.9 million in 2024, then grew by 25.68% to $22.5 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $22.5 million (Q4 2025), $22.0 million (Q3 2025), and $21.5 million (Q2 2025) per Business Quant data.